Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

BackgroundWe evaluated the efficacy and safety of acarbose add-on therapy in Korean patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with metformin and sitagliptin.MethodsA total of 165 subjects were randomized to metformin and sitagliptin (Met+Sita, n=65), metformin, si...

Full description

Bibliographic Details
Main Authors: Hae Kyung Yang, Seung-Hwan Lee, Juyoung Shin, Yoon-Hee Choi, Yu-Bae Ahn, Byung-Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon
Format: Article
Language:English
Published: Korean Diabetes Association 2019-06-01
Series:Diabetes & Metabolism Journal
Subjects:
acarbose
diabetes mellitus, type 2
drug therapy, combination
metformin
sitagliptin phosphate
Online Access:http://e-dmj.org/upload/pdf/dmj-43-287.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-43-287.pdf

Similar Items